Taylor Soper’s Post

Exciting news in the journey toward truly personalized healthcare! Truveta's $320M funding and groundbreaking Genome Project mark a major step in understanding the interplay of genetics and health at an unprecedented scale. This initiative holds the promise of advancing precision medicine and transforming early detection and prevention efforts. #HealthcareInnovation #PrecisionMedicine #Genomics

If any Founder is looking for an example of a boldly compelling 𝘴𝘩𝘢𝘳𝘦𝘥 𝘱𝘶𝘳𝘱𝘰𝘴𝘦 statement [an inspiring description of what everyone in the organization is trying to do together] you will find none better than "𝘂𝗻𝗿𝗮𝘃𝗲𝗹 𝘁𝗵𝗲 𝗰𝗮𝘂𝘀𝗮𝗹 𝗯𝗶𝗼𝗹𝗼𝗴𝘆 𝗼𝗳 𝗱𝗶𝘀𝗲𝗮𝘀𝗲." This is a tremendously energising video from PrecisionLife, a serious company driving humanity-level innovation. #Founder #leadership #entrepreneur #inspiration #sharedpurpose #employerbrand #employervaleproposition #EveryoneNeedsHelp

In case you missed it: our Chief Strategy Officer Mirja Riester and Digital Developer Crystal Gaskin shared insights from a successful case study on how to meaningfully and effectively engage underserved patient populations. Learn how our research-driven approach built trust and credibility in the community with the goal of transforming patient perceptions of long-term disease management. Plus, see how we can apply these insights to other underserved patient populations. You can catch the full presentation here: bit.ly/3KAe6VA #DigitalPharmaInnovationWeek Fierce Pharma #PharmaMarketing

The time has come for iDPP@CLEF 2024! #CLEF2024 will be a special edition, since it marks the 25th anniversary of CLEF, an achievement all the community is proud of. The objective of iDPP@CLEF is to develop AI-based approaches to describe the progression of these diseases. The ultimate goal is to enable #patient stratification and predict disease progression, thereby assisting #clinicians in providing timely care. iDPP@CLEF 2024 continues the work of the previous editions, iDPP@CLEF 2022 and 2023. This edition extends the MS dataset with #environmentaldata and introduces two new #ALS tasks aimed at predicting disease progression using data from #wearabledevices. This marks the first iDPP edition to utilize prospective data directly collected from patients involved in the BRAINTEASER Project. Learn more: https://lnkd.in/d-pHgnBy

Excited to join Arab Health! I'll be discussing PrecisionLife's #AI-led #Genomic analysis, creating predictive models for disease risk and therapy response in diverse populations. This ground breaking innovation paves the way for personalized chronic disease care, ushering in a new era of predictive and preventative healthcare. Connect with me on the App or here for more details. Catch me at the #healthcareinvestmentsummit on 28 Jan as well. #ArabHealth #ArabHealth25 #digitalhealth #genomichealth #precisionmedicine #chronicdisease

Dr. Kapil Raina, Brian Williams, and Chris Zealey share launch planning best practices for rare disease therapies, including budgeting, resource allocation, and stakeholder engagement strategies: https://lnkd.in/eSa2tdzX #AskHerspiegel #CommercialConversation #RareDisease #LaunchPlan

May is #ALSAwarenessMonth! At Firma, we stand in solidarity with the ALS community in their fight against this devastating disease. Our commitment to advancing #ClinicalResearch extends to finding innovative solutions for ALS treatments through decentralized trials and cutting-edge #biometrics. Together, let's raise awareness, support patients, and strive for a future without ALS. See more about this → https://bit.ly/3oZScnh See our "ALS Platform Trial" case study here: https://bit.ly/3QhnWip

Calling all DC based diagnostics technology enthusiasts! If you're also going to Next Generation Dx Summit, please stop by our presentation on August 21st and learn more about the clinical evidence behind Daye's Diagnostic Tampon for HPV screening. #Diagnostics #STIs #HPV #CervicalCancer #ClinicalTrials

Exciting news for myositis research! At the first Myositis Common Data Elements (CDE) Consensus Conference, global experts worked to standardize tools for collecting patient data, paving the way for better diagnosis and treatment. Three representatives from TMA participated in this effort, bringing patient voices to this cutting-edge method for shaping the future of autoimmune disease studies. Read the full article here: https://lnkd.in/dMUD6P2G #Myositis #MyositisWarrior #MyositisAwareness #TheMyositisAssociation #MyositisSupport #RareDisease #MYOMovement #MyositisLife #MyTMA #PatientAdvocacy #TheMyositisAgenda

Dr. Kapil Raina, Brian Williams, and Chris Zealey share launch planning best practices for rare disease therapies, including budgeting, resource allocation, and stakeholder engagement strategies: https://bit.ly/4i5I5nW #AskHerspiegel #CommercialConversation #RareDisease #LaunchPlan